Auckland, 27 August 2008 – A2 Corporation (NZAX: ATM) (A2C) announced today that it has reached agreement with the Child Health Research Foundation (CHRF) to exchange CHRF’s A2C profit share entitlement for a 5% shareholding in A2C. The entitlement is 13,915,962 shares based on the number of shares on issue following the recently completed $11.3 million rights issue to existing shareholders.
Cliff Cook, Chairman of A2C says “We are delighted that we have been able to reach agreement with the Foundation and we see this as a win for both parties.”
Roy Austin, Chairman of Child Health Research says that the charitable organisation is very pleased with this outcome. Entering into this agreement also heralds a new era in the relationship between the A2C and Child Health.
The issue of shares to CHRF will occur in the next few days following completion of final documentation.
For more information please contact:
Cliff Cook, Chairman, A2 Corporation, Ph +64 9 309 1700
Roy Austin, Chairman, Child Health Research Foundation, Ph 09 355 1480
Julien Leys, JML Communications, Mobile +64 21 655 598
About A2 Corporation
A2 Corporation Ltd owns and licenses intellectual property that enables the identification of cattle for the production and subsequent marketing of a2 milk™. a2 milk™ is naturally produced to contain maximum amounts of a milk protein variant that is associated by a number of studies with potential benefits in some individuals. A2 Corporation Ltd receives royalty income from sales of a2 milk™ products and testing for A2 cattle, and shares in the profits or losses of associates and subsidiaries formed for those purposes.
About Child Health Research Foundation
The Child Health Research Foundation (CHRF or Cure Kids) is an organisation established over 30 years ago to address the lack of research into life-threatening childhood illnesses in New Zealand.
Since then, CHRF have invested over $19 million in medical research. This research has helped save hundreds of young lives and has improved the quality of life for thousands of children.
Today, CHRF are more committed than ever to help find answers to the many cruel, life-threatening illnesses that devastate the lives of young children and their families.
CHRF successes include:
· Breakthroughs into the causes of childhood leukaemia
· Childhood Diabetes
· Childhood Heart Conditions
· Internationally adopted treatment fr cystic fibrosis
· Life-saving cot death preventative strategies
· Liver Disease
· Molecular Genetics
· Paediatric Cancer
· Placental cord Blood Banking
· Respiratory Illnesses
· Rheumatic Fever
· Spina Bifida
· Treatment for hole in the heart blue babies
· World-first breakthroughs into genetic research